Journal profile · INFECTIOUS DISEASES
IDCases
ISSN 2214-2509 · Elsevier · United Kingdom
IDCases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.9 (journal website); fully open access; APC about USD 1,750; median 66 days to acceptance (123 articles, last 24 months); 337 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
IDCases is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Streptococcal Infections and Treatments, Infective Endocarditis Diagnosis and Management and Fungal Infections and Studies, together about 25.5% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
IDCases is dedicated to publishing original single and series case reports in all aspects of infectious diseases. The journal also recognizes the important link between human and animal health; instructive reports from the veterinary medicine perspective can be useful in the cross-disciplinary understanding of infectious diseases.IDCases aims to reach an international audience of healthcare professionals. It publishes articles on instructive reports that expand the body of infectious diseases knowledge.The journal publishes topics including:• Unusual clinical presentations • Unexpected or unusual clinical course or outcome • Unexpected or unusual drug adverse reactions • Unusual disease associations • Diagnostic conundrums • Illustrative medical images • Rare diseases • Novel aspects of zoonotic diseases
From the journal's Aims & Scope
Research area (LetPub): INFECTIOUS DISEASES
Editor-in-chief Zelalem TemesgenPublisher website
Editorial board by country: none in mainland China; most named United States 29, Iran 4, Brazil 2, Vietnam 2, United Kingdom 1 (42 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Streptococcal Infections and TreatmentsMedicine9.2%
- Infective Endocarditis Diagnosis and ManagementMedicine8.9%
- Fungal Infections and StudiesMedicine7.4%
- Antifungal resistance and susceptibilityMedicine7.1%
- Infectious Diseases and TuberculosisMedicine6.8%
- Mycobacterium research and diagnosisMedicine4.6%
- Bacterial Infections and VaccinesImmunology and Microbiology3.7%
- Infectious Diseases and MycologyVeterinary3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.9Publisher website ·
- CiteScore 2026-06
- 1.6LetPub ·
- CiteScore (publisher)
- 1.6Publisher website ·
- SJR 2026-06
- 0.3LetPub ·
- SNIP 2026-06
- 0.58LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 471OpenAlex ·
- 2-year mean citedness
- 0.81OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 293LetPub ·
Articles by year OpenAlex count · 2,791 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 302 | 302 | 23 |
| 2025 | 337 | 337 | 271 |
| 2024 | 216 | 216 | 402 |
| 2023 | 247 | 247 | 863 |
| 2022 | 302 | 302 | 1,485 |
| 2021 | 333 | 333 | 2,020 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
66 daysMedian, submission to acceptance · P25–P75 40 days – 121 days
- Acceptance to online
- median 2 days (123 articles)
- Submission to online
- median 70 days
- Sample
- 123 articles with submission and acceptance dates (680 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- First decision after review
- 61 daysPublisher website ·
- Submission to acceptance
- 81 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,750 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 1,370 / EUR 1,280 / GBP 1,100 / JPY 169,920 | — | — | |
| LetPub | USD 900 | Yes | — | |
| Publisher website | USD 2,150 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted4
- case illustratedWe would also like to invite submissions of high-quality, interesting and instructive images (such as clinical and other photographs, figures or diagrams, photo…Length not stated
- case reportCase ReportsA Case Report is a brief description of a particular condition that is unusual and also provides new insights into diagnosis or clinical management.…Length not stated
- case reportsA Case Report is a brief description of a particular condition that is unusual and also provides new insights into diagnosis or clinical management.Length not stated
- curated case reports in hiv infection"Curated Case Reports in HIV Infection”— is a by-invitation-only article category dedicated to advancing HIV clinical expertise through systematically curated p…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2214-2509
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about IDCases
What CAS zone is IDCases in?
In the 2025 upgraded edition of the CAS Journal Ranking, IDCases is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of IDCases?
The journal's website gives an impact factor of 0.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 1.6, h-index 39.
How long does peer review take at IDCases?
Based on the dates recorded on 123 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 66 days (interquartile range 40–121 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of IDCases based?
Of the 42 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (29), Iran (4) and Brazil (2). Counted from the institutions listed on the board page; for reference only.
Which databases index IDCases?
According to LetPub and DOAJ records, IDCases is indexed in ESCI, Scopus and DOAJ.
Is IDCases open access, and what is the APC?
IDCases is a fully open-access journal. APC about USD 1,750.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .